This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Atopic Dermatitis: Improving Outcomes Through a Patient-Centered Approach

Atopic Dermatitis: Improving Outcomes Through a Patient-Centered Approach

Format

Webcast

Time to Complete

1 hour

Released

August 2, 2019

Expires

August 2, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour (1.00 pharmacology credit)

Accredited Provider

This enduring activity is jointly provided by Talem MedEd and Boston University School of Medicine.

Commercial Supporter

This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Program Description

Atopic dermatitis is a chronic inflammatory skin disease that affects approximately 16.5 million adults and 9.6 million children in the United States, with prevalence rates on the rise. This underrecognized and undertreated condition is a clinically significant cause of morbidity, quality-of-life impairment, and healthcare costs, and is a major public health concern. For many patients, moderate-to-severe symptoms persist throughout their life and are inadequately controlled on standard treatments. Given the recent discoveries regarding immune dysregulation underlying atopic dermatitis as well as new targeted therapies that have been developed based on these findings, this CME/CE program is designed to update primary care clinicians on the latest advances in the pathophysiology, diagnosis, and management of atopic dermatitis.

Intended Audience

This activity is designed specifically for primary care clinicians, nurses, and other members of the healthcare team.

Educational Objectives

After completing this activity, participants should be better able to:

  • Describe the pathophysiology and immunologic factors associated with atopic dermatitis
  • Apply evidence-based approaches to assess and diagnose atopic dermatitis
  • Summarize safety and efficacy data on new and emerging targeted therapies for moderate-to-severe atopic dermatitis
  • Describe the relationship between atopic dermatitis severity and the impact on comorbidities and patients’ quality of life

Conflicts of Interest Disclosure Policy

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Faculty

Peter A. Lio, MD (Activity Chair)
Clinical Assistant Professor of Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Director, Chicago Integrative Eczema Center
Founding Partner, Medical Dermatology Associates of Chicago
Chicago, IL

Dr. Lio has disclosed the following relationships: consultant for AbbVie, Inc., Eli Lilly and Company, Exeltis, Franklin BioScience, Galderma Laboratories, L.P., Heel (Biologische Heilmittel Heel GmbH), Johnson & Johnson Consumer Products Company, Kiniksa Pharmaceuticals, Ltd., L’Oreal USA, Inc., Odeza, LLC, Theraplex, Unilever, and Valeant Pharmaceuticals International; advisory board for Altus Labs, Anacor Pharmaceuticals, Inc., Dermavant Sciences, DermTap, Inc., DermVeda, gpower, Inc., IntraDerm Pharmaceuticals, Johnson & Johnson Consumer Products Company, Menlo Therapeutics, Micreos Human Health Mission, Modernizing Medicine, National Eczema Association, Realm Therapeutics, Regeneron Pharmaceuticals, Inc., Sanofi US Services, Syncere Skin Systems, and UCB, Inc.; speaker for Ferndale Laboratories, Inc., Galderma Laboratories, L.P., Johnson & Johnson Consumer Products Company, La Roche-Posay Laboratorie Pharmaceutique, Micreos Human Health Mission, Pfizer, Inc., Pierre Fabre Dermatologie, Regeneron Pharmaceuticals, Inc., and Valeant Pharmaceuticals North America, LLC; grant/research support from AOBiome, LLC, and La Fondation pour la Dermatite Atopique (Foundation for Atopic Dermatitis); and stockholder in Modernizing Medicine.

Thomas P. Meehan, MD, MPH (Activity Moderator)
Executive Director, Connecticut Center for Primary Care
Vice President, Research and Medical Education
ProHealth Physicians, part of OptumCare
Farmington, CT

Dr. Meehan has no relevant financial conflicts to disclose.

Accredited Provider Disclosure

Karol Timmons, RN, MS, CPNP, CNE Course Advisor, Boston Children’s Hospital, has disclosed the following relationships: NP advisory board for Pfizer, Inc.

The following planning committee members for this activity have no relevant financial relationships to disclose:
Joanna Krause, MPH, Program Manager, Boston University School of Medicine, CME/CNE
Margaret S. Lee, MD, PhD, CME Course Director, Boston University School of Medicine
Carmela Townsend, DNP, MS/MBA, RN, Lead Nurse Planner, Boston University School of Medicine, CME/CNE
Erica Rusie, PharmD, Scientific Director, Scientific Affairs, Talem Health, LLC

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Talem MedEd. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Boston University School of Medicine designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly provided by Talem MedEd.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

Contact Hour: 1.00 of which 1.00 is eligible for pharmacology credit

Disclosure of Unlabeled Use

Faculty do not plan on discussing unlabeled/investigational uses of a commercial product.

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY OR TALEM HEALTH BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.

Copyright Notice Talem MedEd 2019

Instructions

To obtain credit, a score of 60% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this activity, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For any CME or CNE accreditation questions, please email the BUSM CME office at cme@bu.edu.

BUSM CME complies with the ADA and the rules and regulations thereof to make reasonable accommodations for our educational activities. If any participant in this educational activity is in need of accommodations, please contact BUSM CME at 617-358-5005.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue